APC Anti-Mouse CD45 (30-F11)
CD45 Monoclonal Antibody for FC
Host / Isotype
Rat / IgG2b, kappa
Reactivity
mouse
Applications
FC
Conjugate
APC Fluorescent Dye
CloneNo.
30-F11
Cat no : APC-65087
Synonyms
Validation Data Gallery
Tested Applications
Positive FC detected in | mouse splenocytes |
Recommended dilution
Application | Dilution |
---|---|
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Published Applications
FC | See 1 publications below |
Product Information
APC-65087 targets CD45 in FC applications and shows reactivity with mouse samples.
Tested Reactivity | mouse |
Cited Reactivity | mouse |
Host / Isotype | Rat / IgG2b, kappa |
Class | Monoclonal |
Type | Antibody |
Immunogen | Mouse thymus or spleen 相同性解析による交差性が予測される生物種 |
Full Name | protein tyrosine phosphatase, receptor type, C |
GenBank accession number | BC028512 |
Gene symbol | CD45 |
Gene ID (NCBI) | 19264 |
RRID | AB_2882982 |
Conjugate | APC Fluorescent Dye |
Excitation/Emission maxima wavelengths | 650 nm / 660 nm |
Form | Liquid |
Purification Method | Affinity purification |
Storage Buffer | PBS with 0.09% sodium azide. |
Storage Conditions | Store at 2-8°C. Avoid exposure to light. Stable for one year after shipment. |
Background Information
CD45, also known as protein tyrosine phosphatase, receptor type C, is a type I transmembrane protein expressed on the surface of all haematopoietic cells with the exception of erythrocytes and platelets (PMID: 3489673; 28615666). CD45 is a pan-haematopoietic cell marker and has been shown to be essential for T- and B-cell activation and signalling (PMID: 9429890; 16378097).
Protocols
Product Specific Protocols | |
---|---|
FC protocol for APC CD45 antibody APC-65087 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
Acta Biomater Injectable microenvironment-responsive hydrogels with redox-activatable supramolecular prodrugs mediate ferroptosis-immunotherapy for postoperative tumor treatment |